Pherecydes Pharma

France

Retour au propriétaire

1-18 de 18 pour Pherecydes Pharma Trier par
Recheche Texte
Affiner par
Type PI
        Brevet 12
        Marque 6
Juridiction
        International 10
        États-Unis 5
        Canada 3
Date
2021 6
Avant 2020 12
Classe IPC
C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN 7
C12N 7/00 - Virus, p.ex. bactériophages; Compositions les contenant; Leur préparation ou purification 6
A61K 35/76 - Virus; Particules sous-virales; Bactériophages 4
C07K 14/005 - Peptides ayant plus de 20 amino-acides; Gastrines; Somatostatines; Mélanotropines; Leurs dérivés provenant de virus 3
C07K 14/01 - Virus à ADN 3
Voir plus
Classe NICE
05 - Produits pharmaceutiques, vétérinaires et hygièniques 6
10 - Appareils et instruments médicaux 6
42 - Services scientifiques, technologiques et industriels, recherche et conception 6

1.

PHERECYDES PHARMA

      
Numéro d'application 1614337
Statut Enregistrée
Date de dépôt 2021-06-04
Date d'enregistrement 2021-06-04
Propriétaire PHERECYDES PHARMA (France)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Pharmaceutical and veterinary products; pharmaceutical preparations for the treatment or prevention of bacterial diseases; antibacterial substances for medical use; diagnostic agents for medical purposes; drug delivery agents; antibodies for medical or veterinary purposes; hygienic products for medicine; chemical preparations for medical or pharmaceutical use; bacterial and bacteriological preparations for medical or veterinary use; bactericides pertaining to the pharmaceutical trade; fungicides pertaining to the pharmaceutical trade; germicides pertaining to the pharmaceutical trade; virucides pertaining to the pharmaceutical trade; biocides pertaining to the pharmaceutical trade; sporicides pertaining to the pharmaceutical trade; levuricides pertaining to the pharmaceutical trade; mycobactericides pertaining to the pharmaceutical trade; media for bacteriological cultures; microbicides pertaining to the pharmaceutical trade; preparations of microorganisms for medical and veterinary use. Analysis devices for identification of bacteria for medical use; surgical, medical, dental and veterinary apparatus and instruments; bacteria sampling apparatus; apparatus used for the study of bacterial disorders; applicators for anti-bacterial preparations. Medical and pharmacological research services; scientific research in bacteriology; chemical and microbiological laboratory services; research and development in the field of chemistry, microbiology, air flows, agri-foodstuffs, biology, bacteriology; consultancy with respect to pharmaceutical research and development; consultancy with respect to bacteriology research; clinical trials; carrying out clinical trials; auditing regarding air, water and surface hygiene, regarding sanitary risks and chemical or microbiological contamination; surveying [engineering work]; consultancy with respect to bacteriology; research and testing services in the fields of bacteriology and virology; scientific and technological services and research work, particularly for identifying and characterizing active materials for infectious disease treatment; pharmaceutical processing product development; conducting and scientific support of preclinical or clinical studies.

2.

PHERECYDES

      
Numéro d'application 1613460
Statut Enregistrée
Date de dépôt 2021-06-04
Date d'enregistrement 2021-06-04
Propriétaire PHERECYDES PHARMA (France)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Pharmaceutical and veterinary products; pharmaceutical preparations for the treatment or prevention of bacterial diseases; antibacterial substances for medical use; diagnostic agents for medical use; drug delivery agents; antibodies for medical or veterinary use; hygienic products for medicine; chemical preparations for medical or pharmaceutical use; bacterial and bacteriological preparations for medical or veterinary use; bactericides; fungicides; germicides; virucides; biocides; sporicides; levuricides; mycobactericides; media for bacteriological cultures; microbicides; preparations of microorganisms for medical and veterinary use. Analysis devices for identification of bacteria for medical use; surgical, medical, dental and veterinary apparatus and instruments; bacteria sampling apparatus; apparatus used for the study of bacterial disorders; applicators for anti-bacterial preparations. Medical and pharmacological research services; scientific research in bacteriology; chemical and microbiological laboratory services; research and development in the field of chemistry, microbiology, air flows, agri-foodstuffs, biology, bacteriology; consultancy with respect to pharmaceutical research and development; consultancy with respect to bacteriology research; clinical trials; carrying out clinical trials; auditing relating to air, water and surface hygiene, relating to sanitary risks and chemical or microbiological contamination; surveying [engineering work]; consultancy with respect to bacteriology; research and testing services in the fields of bacteriology and virology; scientific and technological services and research work, particularly for identifying and characterizing active materials for infectious disease treatment; development of pharmaceutical treatment products; conducting and scientific support of preclinical or clinical studies.

3.

Miscellaneous Design

      
Numéro d'application 1613461
Statut Enregistrée
Date de dépôt 2021-06-04
Date d'enregistrement 2021-06-04
Propriétaire PHERECYDES PHARMA (France)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Pharmaceutical and veterinary products; pharmaceutical preparations for the treatment or prevention of bacterial diseases; antibacterial substances for medical use; diagnostic agents for medical use; drug delivery agents; antibodies for medical or veterinary use; hygienic products for medicine; chemical preparations for medical or pharmaceutical use; bacterial and bacteriological preparations for medical or veterinary use; bactericides; fungicides; germicides; virucides; biocides; sporicides; levuricides; mycobactericides; media for bacteriological cultures; microbicides; preparations of microorganisms for medical and veterinary use. Analysis devices for identification of bacteria for medical use; surgical, medical, dental and veterinary apparatus and instruments; bacteria sampling apparatus; apparatus used for the study of bacterial disorders; applicators for anti-bacterial preparations. Medical and pharmacological research services; scientific research in bacteriology; chemical and microbiological laboratory services; research and development in the field of chemistry, microbiology, air flows, agri-foodstuffs, biology, bacteriology; consultancy with respect to pharmaceutical research and development; consultancy with respect to bacteriology research; clinical trials; carrying out clinical trials; auditing relating to air, water and surface hygiene, relating to sanitary risks and chemical or microbiological contamination; surveying [engineering work]; consultancy with respect to bacteriology; research and testing services in the fields of bacteriology and virology; scientific and technological services and research work, particularly for identifying and characterizing active materials for infectious disease treatment; development of pharmaceutical treatment products; conducting and scientific support of preclinical or clinical studies.

4.

Miscellaneous Design

      
Numéro de série 79320412
Statut Enregistrée
Date de dépôt 2021-06-04
Date d'enregistrement 2022-12-13
Propriétaire PHERECYDES PHARMA (France)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Pharmaceutical and veterinary products, namely, pharmaceutical preparations for the treatment of viral diseases, plant extracts for veterinary and pharmaceutical purposes; pharmaceutical preparations for the treatment or prevention of bacterial diseases; antibacterial substances for medical use, namely, antibacterial pharmaceuticals, antibacterial soap; diagnostic agents for medical use; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; antibodies for medical or veterinary use, namely, diagnostic kids consisting primarily of monoclonal antibodies for use in disease testing; hygienic products for medicine, namely, disinfectants for hygiene purposes, antibacterial soap; chemical preparations for medical or pharmaceutical use, namely, for the treatment of bacterial infections ; bacterial and bacteriological preparations for medical or veterinary use; bactericides; fungicides; germicides; virucides; biocides; sporicides; levuricides; mycobactericides; media for bacteriological cultures; microbicides; preparations of microorganisms for medical and veterinary use Analysis devices for identification of bacteria for medical use; surgical, medical, dental and veterinary apparatus and instruments, namely, surgical apparatus and instruments for medical use, medical imaging apparatus, ultrasound apparatus for veterinary use; bacteria sampling apparatus, namely, sample preparation device for medical diagnostic uses; Medical instruments for analyzing and identifying bacteria, namely apparatus used for the study of bacterial disorders; drug delivery devices sold empty, namely, applicators for anti-bacterial preparations Medical and pharmacological research services; scientific research in bacteriology; chemical and microbiological laboratory services; research and development in the field of chemistry, microbiology, air flows, agri-foodstuffs, biology, bacteriology; consultancy with respect to pharmaceutical research and development; consultancy with respect to bacteriology research; medical and scientific research, conducting clinical trials for others; medical and scientific research, namely, carrying out clinical trials for others; environmental testing and inspection services, namely, auditing relating to air, water and surface hygiene, relating to sanitary risks and chemical or microbiological contamination; engineering work, namely, surveying; consultancy with respect to bacteriology; research and testing services in the fields of bacteriology and virology; scientific and technological services, namely, scientific and medical research work, particularly for identifying and characterizing active materials for infectious disease treatment; development of pharmaceutical treatment products; medical and scientific research, namely, conducting preclinical or clinical studies and providing scientific support of preclinical or clinical studies

5.

M PHERECYDES PHARMA

      
Numéro de série 79320811
Statut Enregistrée
Date de dépôt 2021-06-04
Date d'enregistrement 2022-10-25
Propriétaire PHERECYDES PHARMA (France)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Pharmaceutical and veterinary products, namely, pharmaceutical preparations for the treatment of viral diseases, plant extracts for veterinary and pharmaceutical purposes; pharmaceutical preparations for the treatment or prevention of bacterial diseases; antibacterial substances for medical use, namely, antibacterial pharmaceuticals, antibacterial soap; diagnostic agents for medical use; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; antibodies for medical or veterinary use, namely, diagnostic kids consisting primarily of monoclonal antibodies for use in disease testing; hygienic products for medicine, namely, disinfectants for hygiene purposes, antibacterial soap; chemical preparations for medical or pharmaceutical use, namely, for the treatment of bacterial infections; bacterial and bacteriological preparations for medical or veterinary use; bactericides pertaining to the pharmaceutical trade; fungicides pertaining to the pharmaceutical trade; germicides pertaining to the pharmaceutical trade; virucides pertaining to the pharmaceutical trade; biocides pertaining to the pharmaceutical trade; sporicides pertaining to the pharmaceutical trade; levuricides pertaining to the pharmaceutical trade; mycobactericides pertaining to the pharmaceutical trade; media for bacteriological cultures; microbicides; preparations of microorganisms for medical and veterinary use Analysis devices for identification of bacteria for medical use; surgical, medical, dental and veterinary apparatus and instruments, namely, surgical apparatus and instruments for medical use, medical imaging apparatus, ultrasound apparatus for veterinary use; bacteria sampling apparatus, namely, sample preparation device for medical diagnostic uses; Medical instruments for analyzing and identifying bacteria, namely, apparatus used for the study of bacterial disorders; drug delivery devices sold empty, namely, applicators for anti-bacterial preparations Medical and pharmacological research services; scientific research in bacteriology; chemical and microbiological laboratory services; research and development in the field of chemistry, microbiology, air flows, agri-foodstuffs, biology, bacteriology; consultancy with respect to pharmaceutical research and development; consultancy with respect to bacteriology research; medical and scientific research, conducting clinical trials for others; medical and scientific research, namely, carrying out clinical trials for others; environmental testing and inspection services, namely, auditing relating to air, water and surface hygiene, relating to sanitary risks and chemical or microbiological contamination; engineering work, namely, surveying ; consultancy with respect to bacteriology; research and testing services in the fields of bacteriology and virology; scientific and technological services, namely, scientific and medical research work, particularly for identifying and characterizing active materials for infectious disease treatment; development of pharmaceutical treatment products; medical and scientific research, namely, conducting preclinical or clinical studies and providing scientific support of preclinical or clinical studies

6.

PHERECYDES

      
Numéro de série 79320411
Statut Enregistrée
Date de dépôt 2021-06-04
Date d'enregistrement 2022-12-13
Propriétaire PHERECYDES PHARMA (France)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Pharmaceutical and veterinary products, namely, pharmaceutical preparations for the treatment of viral diseases, plant extracts for veterinary and pharmaceutical purposes; pharmaceutical preparations for the treatment or prevention of bacterial diseases; antibacterial substances for medical use, namely, antibacterial pharmaceuticals, antibacterial soap; diagnostic agents for medical use; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; antibodies for medical or veterinary use, namely, diagnostic kids consisting primarily of monoclonal antibodies for use in disease testing; hygienic products for medicine, namely, disinfectants for hygiene purposes, antibacterial soap; chemical preparations for medical or pharmaceutical use, namely, for the treatment of bacterial infections ; bacterial and bacteriological preparations for medical or veterinary use; bactericides; fungicides; germicides; virucides; biocides; sporicides; levuricides; mycobactericides; media for bacteriological cultures; microbicides; preparations of microorganisms for medical and veterinary use Analysis devices for identification of bacteria for medical use; surgical, medical, dental and veterinary apparatus and instruments, namely, surgical apparatus and instruments for medical use, medical imaging apparatus, ultrasound apparatus for veterinary use; bacteria sampling apparatus, namely, sample preparation device for medical diagnostic uses; Medical instruments for analyzing and identifying bacteria, namely, apparatus used for the study of bacterial disorders; drug delivery devices sold empty, namely, applicators for anti-bacterial preparations Medical and pharmacological research services; scientific research in bacteriology; chemical and microbiological laboratory services; research and development in the field of chemistry, microbiology, air flows, agri-foodstuffs, biology, bacteriology; consultancy with respect to pharmaceutical research and development; consultancy with respect to bacteriology research; medical and scientific research, conducting clinical trials for others; medical and scientific research, namely, carrying out clinical trials for others; environmental testing and inspection services, namely, auditing relating to air, water and surface hygiene, relating to sanitary risks and chemical or microbiological contamination; engineering work, namely, surveying; consultancy with respect to bacteriology; research and testing services in the fields of bacteriology and virology; scientific and technological services, namely, scientific and medical research work, particularly for identifying and characterizing active materials for infectious disease treatment; development of pharmaceutical treatment products; medical and scientific research, namely, conducting preclinical or clinical studies and providing scientific support of preclinical or clinical studies

7.

PHAGE THERAPY

      
Numéro d'application EP2018055629
Numéro de publication 2018/162566
Statut Délivré - en vigueur
Date de dépôt 2018-03-07
Date de publication 2018-09-13
Propriétaire PHERECYDES PHARMA (France)
Inventeur(s)
  • Fevre, Cindy
  • Blois, Hélène
  • Medina, Mathieu

Abrégé

The present invention relates to bacteriophage therapy. More particularly, the present invention relates to novel bacteriophages having a high specificity against Staphylococcus aureus strains, their manufacture, components thereof, compositions comprising the same and the uses thereof in phage therapy and as companion diagnostic.

Classes IPC  ?

  • A01N 63/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des micro-organismes, des virus, des champignons microscopiques, des animaux ou des substances produites par, ou obtenues à partir d
  • A61K 35/76 - Virus; Particules sous-virales; Bactériophages
  • C07K 14/01 - Virus à ADN
  • C12N 7/00 - Virus, p.ex. bactériophages; Compositions les contenant; Leur préparation ou purification

8.

PHAGE THERAPY

      
Numéro d'application EP2015075949
Numéro de publication 2016/071503
Statut Délivré - en vigueur
Date de dépôt 2015-11-06
Date de publication 2016-05-12
Propriétaire PHERECYDES PHARMA (France)
Inventeur(s)
  • Pouillot, Flavie
  • Blois, Hélène

Abrégé

The present invention relates to bacteriophage therapy. More particularly, the present invention relates to novel bacteriophages having a high specificity against Pseudomonas aeruginosa strains, their manufacture, components thereof, compositions comprising the same and the uses thereof in phage therapy.

Classes IPC  ?

  • C12N 7/00 - Virus, p.ex. bactériophages; Compositions les contenant; Leur préparation ou purification
  • A61K 35/76 - Virus; Particules sous-virales; Bactériophages

9.

PHAGE THERAPY OF E COLI INFECTIONS

      
Numéro d'application EP2015050355
Numéro de publication 2015/104388
Statut Délivré - en vigueur
Date de dépôt 2015-01-09
Date de publication 2015-07-16
Propriétaire PHERECYDES PHARMA (France)
Inventeur(s)
  • Pouillot, Flavie
  • Blois, Hélène

Abrégé

The present invention relatesto bacteriophage therapy. More particularly, the present invention relates to novel bacteriophages having a high specificity against Escherichia colis trains, their manufacture, components thereof, compositions comprising the same and the uses thereof in phage therapy.

Classes IPC  ?

  • A61K 35/76 - Virus; Particules sous-virales; Bactériophages
  • C07K 14/005 - Peptides ayant plus de 20 amino-acides; Gastrines; Somatostatines; Mélanotropines; Leurs dérivés provenant de virus
  • C12N 7/00 - Virus, p.ex. bactériophages; Compositions les contenant; Leur préparation ou purification
  • C12Q 1/70 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismes; Compositions à cet effet; Procédés pour préparer ces compositions faisant intervenir des virus ou des bactériophages
  • G01N 33/569 - Tests immunologiques; Tests faisant intervenir la formation de liaisons biospécifiques; Matériaux à cet effet pour micro-organismes, p.ex. protozoaires, bactéries, virus

10.

PHAGE THERAPY OF PSEUDOMONAS INFECTIONS

      
Numéro d'application EP2014072905
Numéro de publication 2015/059298
Statut Délivré - en vigueur
Date de dépôt 2014-10-24
Date de publication 2015-04-30
Propriétaire PHERECYDES PHARMA (France)
Inventeur(s)
  • Pouillot, Flavie
  • Blois, Hélène

Abrégé

The present invention relates to bacteriophage therapy. More particularly, the present invention relates to novel bacteriophages having a high specificity against Pseudomonas aeruginosa strains, their manufacture, components thereof, compositions comprising the same and the uses thereof in phage therapy.

Classes IPC  ?

  • A61K 35/76 - Virus; Particules sous-virales; Bactériophages
  • C12N 7/00 - Virus, p.ex. bactériophages; Compositions les contenant; Leur préparation ou purification
  • C07K 14/005 - Peptides ayant plus de 20 amino-acides; Gastrines; Somatostatines; Mélanotropines; Leurs dérivés provenant de virus
  • C12N 15/33 - Gènes codant pour des protéines virales

11.

Modification of the genome of a lytic bacteriophage by immobilizing said bacteriophage in the host bacterium thereof

      
Numéro d'application 13266836
Numéro de brevet 09029153
Statut Délivré - en vigueur
Date de dépôt 2010-04-27
Date de la première publication 2012-02-16
Date d'octroi 2015-05-12
Propriétaire Pherecydes Pharma (France)
Inventeur(s)
  • Pouillot, Flavie
  • Iris, Francois

Abrégé

The present invention relates to a method for the reversible immobilization of lytic bacteriophages within their modified bacterial hosts. It relates more particularly to a method for modifying the genome of a lytic bacteriophage by immobilizing said bacteriophage in the host bacterium thereof.

Classes IPC  ?

  • C07K 14/005 - Peptides ayant plus de 20 amino-acides; Gastrines; Somatostatines; Mélanotropines; Leurs dérivés provenant de virus
  • C07K 14/245 - Escherichia (G)
  • C12N 15/02 - Préparation de cellules hybrides par fusion de plusieurs cellules, p.ex. fusion de protoplastes
  • C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli
  • C12N 11/16 - Enzymes ou cellules microbiennes immobilisées sur ou dans une cellule biologique
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN

12.

Method for the random diversification of a genetic sequence while preserving the identity of some inner segments of said genetic sequence

      
Numéro d'application 12528257
Numéro de brevet 08728734
Statut Délivré - en vigueur
Date de dépôt 2007-12-18
Date de la première publication 2011-03-03
Date d'octroi 2014-05-20
Propriétaire Pherecydes Pharma (France)
Inventeur(s) Iris, Francois

Abrégé

The invention relates to a very general method for the random diversification of a nucleotide sequence S by PCR while preserving the identity of some domains of said sequence S; the invention also relates to a bank of nucleotide sequence thus diversified, and to diversified proteins obtained by the expressions of the nucleotide sequences in an appropriate host.

Classes IPC  ?

  • C12Q 1/68 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismes; Compositions à cet effet; Procédés pour préparer ces compositions faisant intervenir des acides nucléiques
  • C12P 19/34 - Polynucléotides, p.ex. acides nucléiques, oligoribonucléotides

13.

MODIFICATION OF THE GENOME OF A LYTIC BACTERIOPHAGE BY IMMOBILIZING SAID BACTERIOPHAGE IN THE HOST BACTERIUM THEREOF

      
Numéro de document 02760275
Statut Délivré - en vigueur
Date de dépôt 2010-04-27
Date de disponibilité au public 2010-11-04
Date d'octroi 2017-08-22
Propriétaire PHERECYDES PHARMA (France)
Inventeur(s)
  • Pouillot, Flavie
  • Iris, Francois

Abrégé

The invention relates to a method for modifying the genome of a lytic bacteriophage by immobilizing said bacteriophage in the host bacterium thereof.

Classes IPC  ?

  • C07K 14/01 - Virus à ADN
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN

14.

MODIFICATION OF THE GENOME OF A LYTIC BACTERIOPHAGE BY IMMOBILIZING SAID BACTERIOPHAGE IN THE HOST BACTERIUM THEREOF

      
Numéro d'application FR2010050796
Numéro de publication 2010/125296
Statut Délivré - en vigueur
Date de dépôt 2010-04-27
Date de publication 2010-11-04
Propriétaire PHERECYDES PHARMA (France)
Inventeur(s)
  • Pouillot, Flavie
  • Iris, François

Abrégé

The invention relates to a method for modifying the genome of a lytic bacteriophage by immobilizing said bacteriophage in the host bacterium thereof.

Classes IPC  ?

  • C07K 14/01 - Virus à ADN
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN

15.

METHOD FOR THE RANDOM DIVERSIFICATION OF A GENETIC SEQUENCE WHILE PRESERVING THE IDENTITY OF SOME INNER SEGMENTS OF SAID GENETIC SEQUENCE

      
Numéro de document 02673004
Statut Délivré - en vigueur
Date de dépôt 2007-12-18
Date de disponibilité au public 2008-08-07
Date d'octroi 2017-11-21
Propriétaire PHERECYDES PHARMA (France)
Inventeur(s) Iris, Francois

Abrégé

The invention relates to a very general method for the random diversification of a nucleotide sequence S by PCR while preserving the identity of some domains of said sequence S; the invention also relates to a bank of nucleotide sequence thus diversified, and to diversified proteins obtained by the expressions of the nucleotide sequences in an appropriate host.

Classes IPC  ?

  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • C40B 10/00 - CHIMIE COMBINATOIRE; BIBLIOTHÈQUES, p.ex. CHIMIOTHÈQUES Évolution moléculaire dirigée des macromolécules, p.ex. ARN, ADN ou protéines

16.

METHOD FOR PREPARING BACTERIOPHAGES MODIFIED BY THE INSERTION OF RANDOM SEQUENCES IN THE SCREENING PROTEINS OF SAID BACTERIOPHAGES

      
Numéro d'application FR2007002101
Numéro de publication 2008/093009
Statut Délivré - en vigueur
Date de dépôt 2007-12-18
Date de publication 2008-08-07
Propriétaire PHERECYDES PHARMA (France)
Inventeur(s) Iris, François

Abrégé

The invention relates to a method for obtaining a variety of recombinant bacteriophages in which the screening proteins have been modified by the insertion in their genetic sequence of randomly produced oligonucleotides, and to bacteriophages banks that can be obtained according to said method.

Classes IPC  ?

  • C12N 7/01 - Virus, p.ex. bactériophages, modifiés par l'introduction de matériel génétique étranger
  • C12N 7/00 - Virus, p.ex. bactériophages; Compositions les contenant; Leur préparation ou purification
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • C12Q 1/70 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismes; Compositions à cet effet; Procédés pour préparer ces compositions faisant intervenir des virus ou des bactériophages

17.

METHOD FOR PREPARING BACTERIOPHAGES MODIFIED BY THE INSERTION OF RANDOM SEQUENCES IN THE SCREENING PROTEINS OF SAID BACTERIOPHAGES

      
Numéro de document 02673579
Statut Délivré - en vigueur
Date de dépôt 2007-12-18
Date de disponibilité au public 2008-08-07
Date d'octroi 2019-04-09
Propriétaire PHERECYDES PHARMA (France)
Inventeur(s) Iris, Francois

Abrégé

The invention relates to a method for obtaining a variety of recombinant bacteriophages in which the screening proteins have been modified by the insertion in their genetic sequence of randomly produced oligonucleotides, and to bacteriophages banks that can be obtained according to said method.

Classes IPC  ?

  • C12N 7/01 - Virus, p.ex. bactériophages, modifiés par l'introduction de matériel génétique étranger
  • C12N 7/00 - Virus, p.ex. bactériophages; Compositions les contenant; Leur préparation ou purification
  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • C12Q 1/70 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismes; Compositions à cet effet; Procédés pour préparer ces compositions faisant intervenir des virus ou des bactériophages

18.

METHOD FOR THE RANDOM DIVERSIFICATION OF A GENETIC SEQUENCE WHILE PRESERVING THE IDENTITY OF SOME INNER SEGMENTS OF SAID GENETIC SEQUENCE

      
Numéro d'application FR2007002102
Numéro de publication 2008/093010
Statut Délivré - en vigueur
Date de dépôt 2007-12-18
Date de publication 2008-08-07
Propriétaire PHERECYDES PHARMA (France)
Inventeur(s) Iris, François

Abrégé

The invention relates to a very general method for the random diversification of a nucleotide sequence S by PCR while preserving the identity of some domains of said sequence S; the invention also relates to a bank of nucleotide sequence thus diversified, and to diversified proteins obtained by the expressions of the nucleotide sequences in an appropriate host.

Classes IPC  ?

  • C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
  • C40B 10/00 - CHIMIE COMBINATOIRE; BIBLIOTHÈQUES, p.ex. CHIMIOTHÈQUES Évolution moléculaire dirigée des macromolécules, p.ex. ARN, ADN ou protéines